According to the ESTIMATE algorithm, significant correlations between ZNF419 expression and the content of both immune and stromal cells in the TME were identified in more than 20 cancer types, and most of them were negative, where PRAD, KIRA, LUSC, LIHC, and BLCA were representative cancer types. Here, ZNF419 is linked to cancer.